Overview

Safety and Efficacy Study of AzaSiteĀ® in Subjects With Blepharitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and efficacy of AzaSiteĀ® ophthalmic solution, 1% on signs & symptoms of blepharitis and tear cytokine and eyelid bacterial load levels
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Azithromycin
Ophthalmic Solutions
Criteria
Inclusion Criteria:

- Diagnosis of moderate to severe chronic blepharitis

- If female of childbearing potential, are non-pregnant and non-lactating

Exclusion Criteria:

- Had ocular surface surgery (LASIK, refractive, etc.) within the past year

- Unwilling to discontinue use of contact lenses during the study

- Have glaucoma

- Unable or unwilling to withhold the use of lid scrubs during the study

- Have a serious systemic disease or uncontrolled medical condition that in the judgment
of the investigator could confound study assessments or limit compliance

- Currently using any preserved topical ocular medications (with the exception of
unpreserved tear substitutes) at the time of entry into the study or during study
participation